BlackRock, Inc. 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
6,577,879 5.800% |
-1,216,338 (-15.61%) |
Filing |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
7,794,217 7.800% |
0 (Unchanged) |
Filing |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
7,794,217 7.800% |
4,005,535 (+105.72%) |
Filing |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
3,788,682 6.200% |
1,195,158 (+46.08%) |
Filing |
| 2023-02-09 11:01 am Sale |
2023-01-31 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
2,593,524 4.900% |
-25,094 (-0.96%) |
Filing |
| 2023-02-08 2:57 pm Purchase |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
2,618,618 5.000% |
2,618,618 (New Position) |
Filing |